Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial
Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Naoki Yamamoto, Hiroto Kawashima, Koji Ichiyama, Rajappa Senthilkumar, Senthilkumar Preethy, View ORCID ProfileSamuel JK Abraham
doi: https://doi.org/10.1101/2023.09.07.23295172
Vidyasagar Devaprasad Dedeepiya
1Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Chockanathan Vetrievel
2Be Well Hospitals, Chennai, Tamil Nadu, India
Nobunao Ikewaki
3Dept. of Medical Life Science, Kyushu University of Health and Welfare, Japan
4Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
Naoki Yamamoto
5National Centre for Global health and Medicine (NCGM), Chiba, Japan
Hiroto Kawashima
6Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
Koji Ichiyama
7Antony-Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
Rajappa Senthilkumar
7Antony-Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
8Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Senthilkumar Preethy
8Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Samuel JK Abraham
1Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
7Antony-Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
9R & D, Sophy Inc., Japan
10Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
11Levy-Jurgen Transdisciplinary Exploratory (LJTE), Global Niche Corp., Wilmington, DE, USA
Data Availability
All data generated or analysed during this study are included in the article itself.
Posted September 08, 2023.
Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial
Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Naoki Yamamoto, Hiroto Kawashima, Koji Ichiyama, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2023.09.07.23295172; doi: https://doi.org/10.1101/2023.09.07.23295172
Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial
Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Naoki Yamamoto, Hiroto Kawashima, Koji Ichiyama, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2023.09.07.23295172; doi: https://doi.org/10.1101/2023.09.07.23295172
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)